Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[If I had chronic polyarthritis--current ideas on basic therapy]

F Hasler1

  • 1FMH Innere Medizin, speziell Rheumaerkrankungen, Chur.

Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|March 23, 1993
PubMed
Summary

Rheumatoid arthritis (RA) management is evolving. Vigorous early treatment with drugs like methotrexate and future therapies such as monoclonal antibodies offer improved outcomes for this chronic inflammatory disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2009
Same author

C60 fullerene: a powerful antioxidant or a damaging agent? The importance of an in-depth material characterization prior to toxicity assays.

Environmental pollution (Barking, Essex : 1987)·2008
Same author

Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA.

Journal of psychopharmacology (Oxford, England)·2008
Same author

[Why do schizophrenic patients smoke?].

Der Nervenarzt·2004
Same author

Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man.

Pharmaceutica acta Helvetiae·1997
Same author

Kinetics and dynamics of orally administered 18 beta-glycyrrhetinic acid in humans.

The Journal of clinical endocrinology and metabolism·1994

Area of Science:

  • Immunology
  • Rheumatology
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) is a chronic inflammatory condition with complex causes.
  • Current RA treatments primarily manage acute inflammation, with suboptimal outcomes.
  • The classical therapeutic pyramid has guided RA management for years.

Purpose of the Study:

  • To discuss the evolving treatment strategies for rheumatoid arthritis.
  • To highlight the shift towards early, aggressive treatment of RA.
  • To introduce emerging therapies for rheumatoid arthritis.

Main Methods:

  • Review of current and emerging rheumatoid arthritis treatment paradigms.
  • Analysis of the role of methotrexate and second-line drugs in early RA.
  • Exploration of future therapeutic targets including monoclonal antibodies and anti-cytokines.

Main Results:

  • Early, aggressive treatment with methotrexate is a key evolving strategy.
  • Monoclonal antibodies and anti-cytokines represent promising future RA therapies.
  • The management of RA is moving towards more targeted and potent interventions.

Conclusions:

  • Vigorous early treatment is crucial for managing rheumatoid arthritis effectively.
  • Future RA therapies will likely involve advanced biologics targeting specific immune pathways.
  • The treatment landscape for rheumatoid arthritis is rapidly advancing.

Related Experiment Videos